Search

everythinglearnresearchcommunity

for

Search:↓

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Finasteride can cause low platelet count in rare cases.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

The model and estimator can predict drug exposure in kidney transplant patients well.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.